Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah B Goldberg

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
The Oncologist|September 28, 2013
Chemotherapy with Erlotinib or chemotherapy alone in advanced non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitorsSarah B Goldberg, Geoffrey R Oxnard, Subba Digumarthy, et al.
JTO Clinical and Research Reports|September 30, 2021
Intracranial Complications From Immune Checkpoint Therapy in a Patient With NSCLC and Multiple Sclerosis: Case ReportBenjamin Y Lu, Cigdem Isitan, Amit Mahajan, et al.
Journal for Immunotherapy of Cancer|August 1, 2019
Perilesional edema in brain metastases: potential causes and implications for treatment with immune therapyThuy T Tran, Amit Mahajan, Veronica L Chiang, et al.
Clinical Lung Cancer|October 27, 2024
Treatment Patterns and Clinical Outcomes in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer After Progression on OsimertinibNathaniel D Robinson, Maureen E Canavan, Peter L Zhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2019
Reply to A. Shinde et alHarriet M Kluger, Kim A Margolin, Michael A Davies, et al.
The Lancet. Oncology|September 21, 2020
Yale Cancer Center Precision Medicine Tumor Board: one tumour, multiple targetsTyler Stewart, Karin Finberg, Zenta Walther, et al.
Journal of Neuro-Oncology|March 10, 2017
Comparing available criteria for measuring brain metastasis response to immunotherapyJack M Qian, Amit Mahajan, James B Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2015
Afatinib plus Cetuximab Delays Resistance Compared to Single-Agent Erlotinib or Afatinib in Mouse Models of TKI-Naïve EGFR L858R-Induced Lung AdenocarcinomaValentina Pirazzoli, Deborah Ayeni, Catherine B Meador, et al.
JCO Precision Oncology|July 12, 2021
Tumor DNA Mutations From Intraparenchymal Brain Metastases Are Detectable in CSFStephanie Kim Cheok, Azeet Narayan, Anna Arnal-Estape, et al.
Clinical Lung Cancer|January 20, 2021
Decreased Overall Survival in HIV-associated Non-small-cell Lung CancerKristen Hysell, Ramsey Yusuf, Lydia Barakat, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
The Oncologist|September 28, 2013
Chemotherapy with Erlotinib or chemotherapy alone in advanced non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitorsSarah B Goldberg, Geoffrey R Oxnard, Subba Digumarthy, et al.
JTO Clinical and Research Reports|September 30, 2021
Intracranial Complications From Immune Checkpoint Therapy in a Patient With NSCLC and Multiple Sclerosis: Case ReportBenjamin Y Lu, Cigdem Isitan, Amit Mahajan, et al.
Journal for Immunotherapy of Cancer|August 1, 2019
Perilesional edema in brain metastases: potential causes and implications for treatment with immune therapyThuy T Tran, Amit Mahajan, Veronica L Chiang, et al.
Clinical Lung Cancer|October 27, 2024
Treatment Patterns and Clinical Outcomes in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer After Progression on OsimertinibNathaniel D Robinson, Maureen E Canavan, Peter L Zhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2019
Reply to A. Shinde et alHarriet M Kluger, Kim A Margolin, Michael A Davies, et al.
The Lancet. Oncology|September 21, 2020
Yale Cancer Center Precision Medicine Tumor Board: one tumour, multiple targetsTyler Stewart, Karin Finberg, Zenta Walther, et al.
Journal of Neuro-Oncology|March 10, 2017
Comparing available criteria for measuring brain metastasis response to immunotherapyJack M Qian, Amit Mahajan, James B Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2015
Afatinib plus Cetuximab Delays Resistance Compared to Single-Agent Erlotinib or Afatinib in Mouse Models of TKI-Naïve EGFR L858R-Induced Lung AdenocarcinomaValentina Pirazzoli, Deborah Ayeni, Catherine B Meador, et al.
JCO Precision Oncology|July 12, 2021
Tumor DNA Mutations From Intraparenchymal Brain Metastases Are Detectable in CSFStephanie Kim Cheok, Azeet Narayan, Anna Arnal-Estape, et al.
Clinical Lung Cancer|January 20, 2021
Decreased Overall Survival in HIV-associated Non-small-cell Lung CancerKristen Hysell, Ramsey Yusuf, Lydia Barakat, et al.
Pageof 11